KR100713564B1 - Oil-in-water makeup cosmetic composition containing a liquid crystal base and a manufacturing method thereof - Google Patents
Oil-in-water makeup cosmetic composition containing a liquid crystal base and a manufacturing method thereof Download PDFInfo
- Publication number
- KR100713564B1 KR100713564B1 KR1020010033712A KR20010033712A KR100713564B1 KR 100713564 B1 KR100713564 B1 KR 100713564B1 KR 1020010033712 A KR1020010033712 A KR 1020010033712A KR 20010033712 A KR20010033712 A KR 20010033712A KR 100713564 B1 KR100713564 B1 KR 100713564B1
- Authority
- KR
- South Korea
- Prior art keywords
- oil
- cosmetic composition
- composition
- liquid crystal
- makeup cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 83
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 41
- 239000002537 cosmetic Substances 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 16
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 29
- 239000000787 lecithin Substances 0.000 claims abstract description 23
- 235000010445 lecithin Nutrition 0.000 claims abstract description 23
- 229940067606 lecithin Drugs 0.000 claims abstract description 23
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 17
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims abstract description 8
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 claims abstract description 7
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims abstract description 7
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 6
- 238000009472 formulation Methods 0.000 claims description 13
- 238000013329 compounding Methods 0.000 claims description 8
- 239000007957 coemulsifier Substances 0.000 claims description 7
- -1 phytosterol Chemical compound 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 5
- 239000011737 fluorine Substances 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 150000002221 fluorine Chemical class 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- JWXLCQHWBFHMOI-NIQMUPOESA-N bis[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] carbonate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C(C1)[C@]2(C)CC[C@@H]1OC(=O)O[C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1 JWXLCQHWBFHMOI-NIQMUPOESA-N 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 239000003995 emulsifying agent Substances 0.000 abstract description 4
- 238000005282 brightening Methods 0.000 abstract description 3
- 150000002222 fluorine compounds Chemical class 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 19
- 238000012360 testing method Methods 0.000 description 16
- 239000003921 oil Substances 0.000 description 13
- 239000000843 powder Substances 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 7
- 239000002994 raw material Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000036572 transepidermal water loss Effects 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000002688 persistence Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- NQDZCRSUOVPTII-UHFFFAOYSA-N 10-methylundecan-1-ol Chemical compound CC(C)CCCCCCCCCO NQDZCRSUOVPTII-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical group C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008571 general function Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940099367 lanolin alcohols Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- ZADYMNAVLSWLEQ-UHFFFAOYSA-N magnesium;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[Mg+2].[Si+4] ZADYMNAVLSWLEQ-UHFFFAOYSA-N 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 수분공급능력, 피부친화력, 우수한 안정성, 가벼운 사용성 등 수중유형 메이크업 조성물의 장점과 내수성, 지속성 등 유중수형 메이크업 조성물의 장점을 모두 가짐으로써, 분산성이 우수하여 색의 선명성이 향상되고 이에 따라 피부색을 밝게 해주는 효과를 가지면서도 제조가 용이한 메이크업 화장료 조성물 및 그의 제조방법에 관한 것으로서, 수소첨가(hydrogenated) 레시틴, 콜레스테롤, 유화제 및 불소화합물을 이용하여 제조한 액정베이스와 이 액정베이스를 이용하여 제조한 수중유형 메이크업 화장료 조성물 및 그의 제조방법에 관한 것이다.The present invention has all the advantages of the oil-in-water makeup composition, such as water supply ability, skin affinity, excellent stability, light usability and the water-in-oil makeup composition, such as water resistance, longevity, excellent dispersibility, thereby improving color clarity According to the present invention, the present invention relates to a makeup cosmetic composition having an effect of brightening the skin color and easy to manufacture, and to a method for preparing the same, using a liquid crystal base prepared using hydrogenated lecithin, cholesterol, an emulsifier, and a fluorine compound. It relates to an oil-in-water makeup cosmetic composition prepared by the step and a manufacturing method thereof.
본 발명에 사용되는 수소첨가 레시틴 조성물의 주요 구성 성분은 포스파티딜콜린(Phosphatidyl choline), 포스파티딜에탄올아민(Phosphatidyl ethanolamine) 및 라이소포스파티딜콜린(Lysophosphatidyl Choline)으로서, 이들의 상대적인 조성은 전체 레시틴 조성물을 중량 기준 100으로 하였을 때 Phosphatidyl choline / Phosphatidyl ethanolamine / Lysophosphatidyl Choline = 67.0-71.0 / 7-11.0 / 0.1-3.0이며, 이렇게 제조된 레시틴 조성물의 배합량은 액정베이스 전체에 대해서 2-20중량%이다.
The main components of the hydrogenated lecithin composition used in the present invention are phosphatidyl choline, phosphatidyl ethanolamine and lysophosphatidyl choline, the relative composition of which is 100% by weight of the total lecithin composition. When Phosphatidyl choline / Phosphatidyl ethanolamine / Lysophosphatidyl Choline = 67.0-71.0 / 7-11.0 / 0.1-3.0, the amount of the lecithin composition thus prepared is 2-20% by weight based on the entire liquid crystal base.
Description
본 발명은 수소첨가(hydrogenated) 레시틴, 콜레스테롤, 유화제 및 불소화합물을 이용하여 액정베이스를 제조하고, 이를 수중유형 에멀젼 메이크업 화장료 제형에 적용하는 메이크업 화장료 조성물 및 그의 제조방법에 관한 것이다.The present invention relates to a makeup cosmetic composition using a hydrogenated lecithin, cholesterol, an emulsifier and a fluorine compound, and applying the same to an oil-in-water emulsion makeup cosmetic formulation, and a method for manufacturing the same.
메이크업 화장료의 일반적인 기능으로는 피부 영양공급, 수렴효과, 보습기능 등의 스킨케어 기능과 피부의 결점을 커버하고, 피부결을 정리하고, 색상에 의해 피부를 아름답게 미화하는 기능 등이 있으며, 이중 피부결점을 커버하는 기능과 색상을 부여하여 피부를 아름답게 하는 기능은 대부분 메이크업 화장료중 파운데이션류에 의해, 구체적으로는 파운데이션류중 안료 성분에 의해 수행된다고 할 수 있다.The general functions of make-up cosmetics include skin care functions such as skin nourishment, astringent effect, and moisturizing function, and cover skin defects, clean up skin texture, and beautify skin beautifully by color. The function to cover the defects and to beautify the skin by giving color is mostly performed by the foundations in the makeup cosmetics, specifically by the pigment component in the foundations.
이와 같은 파운데이션류는 수분 및 영양공급, 피부결점 은폐, 자외선차단기능, 피부미화 효과 등을 위해서는 필수적인 화장료로서, 일반적으로 그 제형에 따 라 유화형 파운데이션, 분산형 파운데이션 및 파우더 파운데이션으로 구분되는데, 이를 좀 더 구체적으로 살펴보면 다음과 같다.Such foundations are essential cosmetics for moisture and nutrient supply, concealing skin defects, sun protection, skin beautification effect, etc., and are generally divided into emulsion foundations, dispersion foundations and powder foundations depending on the formulation. Looking more specifically as follows.
유화형 파운데이션은 안료를 수상 또는 유상에 분산시킨 후 유상 또는 수상을 투입하여 유화시킨 것으로서, 수상 내에 안료와 유성성분을 유화시킨 수중유형 타입과 유상 내에 안료와 수성성분을 유화시킨 유중수형 타입으로 구분된다.Emulsion type foundation is emulsified by dispersing the pigment in the water phase or oil phase, and then emulsifying the oil phase or the water phase. do.
이와 같은 유화형 파운데이션은 중간정도의 커버력을 가지며 다량의 수분이 함유되어 있어 피부친화적 측면에서 유리하므로 밀착 및 지속성이 우수한 장점을 가지고 있으며, 특히 각종 영양성분을 함유시키는데 유리하다. 그러나, 사용이 불편하고 일부 소비자의 경우 유분감이 느껴지는 약점을 안고 있다. 구체적으로, 수중유형 파운데이션은 외상이 수성성분으로 구성되어 유중수형 타입에 비하여 사용성이 가벼우나 시간 경과시 색상유지에 있어서 지속성이 떨어지는 단점이 있으며, 반대로 유중수형은 수중유형에 비하여 밀착 및 지속성은 우수하나 유분감이 느껴지며 사용성이 무겁고 답답한 단점이 있다.Such emulsified foundations have a medium covering power and contain a large amount of moisture, which is advantageous in terms of skin friendliness, and thus has excellent adhesion and sustainability. However, it is inconvenient to use and some consumers feel weak oil. In particular, the oil-in-water foundation is lighter than the water-in-oil type because the external appearance is composed of an aqueous component, but the durability is poor in maintaining color over time. On the contrary, the water-in-oil type has better adhesion and durability than the oil-in-water type. One feels oily and has a heavy and frustrating drawback.
분산형 파운데이션(스킨커버 제형)은 안료를 오일에 분산시킨 제형으로서, 커버력이 가장 높아 피부결점을 커버하기에는 가장 이상적이고 유성성분을 가장 많이 함유하고 있어서 밀착, 지속성이 탁월하다. 그러나, 파우더 및 유화형 타입의 파운데이션에 비하여 피부호흡을 저해하는 정도가 크고 유분감 및 화장막의 두터움으로 인해 사용자가 답답함을 느끼게 된다. 또한, 부자연스러운 화장감을 연출하고, 나아가 발한(Sweating)현상이 발생하는 문제점도 가지고 있다.Dispersible foundation (skin cover formulation) is a formulation in which pigments are dispersed in oil, which has the highest covering power and is ideal for covering skin defects and contains the most oily ingredients, thus providing excellent adhesion and sustainability. However, compared to powder and emulsified type foundation, the degree of inhibiting skin respiration is great and the user feels frustrated due to oiliness and thickening of the makeup film. In addition, there is a problem that the unnatural makeup is produced, and further sweating occurs.
파우더 파운데이션은 안료를 파우더 바인더 및 유상의 바인더에 분무, 혼합 하여 분쇄한 후, 프레스한 것으로 사용이 간편하고 휴대가 용이하여 파운데이션 제형 중 가장 인기 있는 유형이다. 이와 같은 파우더 파운데이션은 유성성분의 함량이 가장 적어 사용성이 가볍고 피지컨트롤 능력이 우수하며 휴대 및 화장의 수정이 용이하나, 사용시 가루날림 현상이 발생하고 분산형 및 유화형 파운데이션에 비하여 유성성분의 함량이 적어 밀착 및 지속성이 떨어지는 단점을 가지므로 화장 후 시간이 경과됨에 따라 파우더가 뭉치는 현상이 발생하게 된다. 또한, 결국에는 화장막이 들뜨며 색상의 변화가 일어나고, 이에 따라 화장막이 붕괴되는 치명적인 약점을 가지고 있다.Powder foundation is the most popular type of foundation formulation because it is sprayed, mixed with a powder binder and an oily binder, pulverized and then pressed, and is easy to use and portable. These powder foundations contain the least amount of oily ingredients, so they are light in usability, have excellent sebum control ability, and are easy to carry and modify.However, powder fluffing occurs during use, and the content of oily ingredients is higher than that of dispersed and emulsified foundations. Since it has a disadvantage of inferior adhesion and persistence, powder agglomeration occurs as time passes after makeup. In addition, the makeup film is lifted up eventually, the color change occurs, and thus the cosmetic film has a fatal weakness that collapses.
이와 같은 파운데이션류의 가장 이상적인 형태는 수중유형이 가지고 있는 수분공급능력, 피부친화력, 우수한 안정성, 가벼운 사용성 등의 장점과 유중수형의 우수한 내수성 및 우수한 지속성 등의 장점을 혼합한 시스템이라고 할 수 있다.The most ideal form of such foundations is a system that combines the advantages of water supply type, skin affinity, excellent stability, light usability, etc., and the advantages of water-in-oil type, such as excellent water resistance and excellent durability.
이러한 목적을 달성하기 위한 방법으로 최근 실리콘의 가벼운 사용성, 내수성 등을 이용한 S/W(실리콘 인 워터) 제형들이 많이 개발되고 있다. 그러나 S/W 제형의 경우 가벼운 사용성, 우수한 지속성 등의 장점을 가지나, 수중유형과 마찬가지로 피부친화성이 없고, 유화 안정성이 부족한 치명적인 약점을 안고 있다.As a method for achieving this purpose, a lot of S / W (silicon in water) formulations using light usability, water resistance, and the like of lately have been developed. However, S / W formulations have advantages such as light usability and excellent sustainability, but like the oil-in-water type, they do not have skin affinity and have fatal weaknesses that lack emulsification stability.
다른 한편으로는 다중유화(유/수/유, 수/유/수 등) 형태로 상기 목적을 달성하고자 하는 연구도 많이 진행되고 있는데, 이 방법은 제조과정이 까다로워서 보편화시키기 어려운 약점을 가지고 있다.On the other hand, a lot of researches to achieve the above object in the form of multi-emulsification (oil / water / oil, water / milk / water, etc.), this method has a weak manufacturing process is difficult to generalize.
더 나아가 최근 산업의 급격한 발전에 따른 자동차의 증가, 냉, 난방 기기 사용의 증가, 대기오염의 심화, 오존층 파괴로 인한 직사 자외선량의 증가, 사회 적 환경의 변화에 따른 정신적 스트레스의 가중 등으로 인해 사람의 피부가 점점 더 약해지고 있는 일반적인 실정을 반영하여, 단순한 피부보호나, 피부미화를 목적으로하는 차원을 넘어서 피부에 원할한 영양공급 및 일반적인 안료의 사용시 올 수 있는 피부의 거칠음 현상 등까지 해소할 수 있는 고기능의 화장료 개발이 절실히 요구되고 있는 실정이다.
Furthermore, due to the recent rapid development of the industry, the increase of automobiles, the use of cold and heating equipment, the deepening of air pollution, the increase of direct ultraviolet rays due to the ozone layer destruction, and the increase of mental stress caused by the change of social environment Reflecting the general situation that human skin is getting weaker, it is not only to protect skin, to beautify skin, but also to provide nutrients to skin and to rough skin that can come from using general pigment. There is an urgent need for the development of highly functional cosmetics.
본 발명은 상기와 같은 종래기술의 문제점을 극복하고자 하는 것으로 그 목적은 수분공급능력, 피부친화력, 우수한 안정성, 가벼운 사용성 등 수중유형 메이크업 조성물의 장점과 내수성, 지속성 등 유중수형 메이크업 조성물의 장점을 모두 가지면서도 제조가 용이한 메이크업 화장료 조성물 및 그의 제조방법을 제공하고자 하는 것이다.The present invention is to overcome the problems of the prior art as described above, the purpose is to provide all the advantages of the oil-in-water makeup composition, such as water supply ability, skin affinity, excellent stability, light usability and water-in-oil makeup composition, such as water resistance, durability It is to provide a makeup cosmetic composition and a method of manufacturing the same easy to manufacture.
이를 위한 본 발명은 포스파티딜콜린(Phosphatidyl choline), 포스파티딜에탄올아민(Phosphatidyl ethanolamine) 및 라이소포스파티딜콜린(Lysophosphatidyl Choline)을 주요 구성 성분으로 하는 레시틴 조성물을 이용하여 액정베이스를 제조하고 이 액정베이스를 이용하여 메이크업 조성물을 제조함으로써, 안정성이 있는 레시틴 함유 메이크업 화장료 조성물 및 그의 제조방법을 제공하는 것으로 이루어진다.
To this end, the present invention provides a liquid crystal base using a lecithin composition comprising phosphatidyl choline, phosphatidyl ethanolamine, and lysophosphatidyl choline as main components, and a makeup composition using the liquid crystal base. The present invention provides a stable lecithin-containing makeup cosmetic composition and a method for producing the same.
상기와 같은 목적을 이루기 위해 본 발명자들은 기존 화장료의 단점을 극복할 수 있는 방법을 다각적으로 연구를 한 결과 레시틴 물질이 피부지질과 유사하다는 점과 고체와 액상의 중간상태인 액정시스템을 이용하면 상기의 목적을 달성할 수 있음에 착안하여 수년간 연구끝에 본 발명을 완수할 수 있었다.In order to achieve the above object, the present inventors have conducted various studies on methods of overcoming the disadvantages of the existing cosmetics. As a result, the lecithin material is similar to the skin lipid and using the liquid crystal system in the intermediate state between the solid and the liquid. Considering that the purpose of the present invention was able to complete the present invention after several years of research.
본 발명에 사용되는 레시틴은 포스파티딜콜린(phosphatidyl choline) 이라고도 하는 생체 구성물질로서 동물 세포막계를 구성하는 주요 인지질(phospholipid) 성분중 하나이며, 피부지질 성분과 유사한 조성을 가지고 있다.Lecithin used in the present invention is a biomaterial, also known as phosphatidyl choline, is one of the major phospholipid components of the animal cell system, and has a composition similar to the skin lipid component.
이와 같은 레시틴은 하기의 분자식과 같이 글리세롤의 한쪽에는 인산 및 콜린 등의 친수성 성분이 결합되고 다른쪽에는 소수성의 아실기가 결합된 구조를 하고 있어서 계면활성을 가지므로, 주로 식품이나 약제의 유화제 등으로 많이 사용되는 물질이다.Such lecithin has a structure in which a hydrophilic component such as phosphoric acid and choline is bonded to one side of glycerol and a hydrophobic acyl group is bonded to the other side, and has surface activity, and thus is mainly used as an emulsifier for food or pharmaceuticals. It is a commonly used substance.
(여기서, R 및 R'는 C14-C22의 아실기이다)Wherein R and R 'are acyl groups of C 14 -C 22
그러나, 이와 같은 레시틴은 상기의 장점에도 불구하고 그 분자 구조가 커 때로는 유화 안정성이 저하되거나 수용성 점증제와 콤플렉스를 형성하여 마무리감촉이 당기게 하는 등의 단점을 가지고 있기 때문에 화장료에의 사용이 극히 저조하였다. However, in spite of the above-mentioned advantages, such lecithin has a disadvantage in that its molecular structure is large and its emulsification stability is sometimes lowered, or it has a disadvantage such as forming a complex with a water-soluble thickener and pulling the finishing texture, so that the use in cosmetics is extremely low. It was.
본 발명자들은 이와 같은 레시틴의 약점을 보완하기 위하여 레시틴 기재를 이용하여 액정을 제조하는 방법을 연구함으로써 본 발명을 완성하였으며, 이하 본 발명을 구체적으로 서술하면 다음과 같다.The present inventors completed the present invention by studying a method for preparing a liquid crystal using a lecithin substrate in order to compensate for the weaknesses of the lecithin, and the present invention will be described in detail below.
본 발명에서는 수첨(하이드로게네이티드) 레시틴/안정화제/보조유화제/변성불소 등을 이용하여 액정을 형성하고 이를 수중유형의 메이크업 화장료 제조에 이용하게 된다.In the present invention, a liquid crystal is formed by using hydrogenated (hydrogenated) lecithin / stabilizer / emulsifier / modified fluorine and the like and used for preparing oil-in-water makeup cosmetics.
먼저 본 발명에 이용된 레시틴을 설명하고자 한다.First, the lecithin used in the present invention will be described.
일반적으로 레시틴은 실제사용시 단일한 화학적 조성이 아닌 여러 종류의 레시틴 및 인지질, 인산 등이 혼합된 조성물 형태로 사용되는데, 그 구체적인 조성에 따라 사용성 및 안정화 정도에 차이가 있으므로 그 조성비가 매우 중요하다고 할 수 있다.In general, lecithin is used in the form of a composition mixed with various kinds of lecithin, phospholipids, and phosphoric acid instead of a single chemical composition in actual use, and its composition ratio is very important because the usability and stabilization degree vary depending on the specific composition. Can be.
본 발명에 사용되는 수소첨가 레시틴 조성물의 주요 구성 성분은 포스파티딜콜린(Phosphatidyl choline), 포스파티딜에탄올아민(Phosphatidyl ethanolamine) 및 라이소포스파티딜콜린(Lysophosphatidyl Choline)으로서, 이들의 상대적인 조성은 전체 레시틴 조성물을 중량 기준 100으로 하였을 때 Phosphatidyl choline / Phosphatidyl ethanolamine / Lysophosphatidyl Choline= 67.0-71.0 / 7-11.0 / 0.1-3.0이며, 이렇게 제조된 레시틴 조성물의 배합량은 액정베이스 전체에 대해서 2-20중량%이다.The main components of the hydrogenated lecithin composition used in the present invention are phosphatidyl choline, phosphatidyl ethanolamine and lysophosphatidyl choline, the relative composition of which is 100% by weight of the total lecithin composition. When Phosphatidyl choline / Phosphatidyl ethanolamine / Lysophosphatidyl Choline = 67.0-71.0 / 7-11.0 / 0.1-3.0, the amount of the lecithin composition thus prepared is 2-20% by weight based on the entire liquid crystal base.
다음으로, 보조유화제는 액정 형성 및 형성된 액정의 안정성에 지대한 영양을 미치게 되는데, 본 발명에 이용된 보조유화제는 HLB(Hydrophilicity/Lipophilicity Balance) 값이 10-15인 에톡실레이트계, 폴리글리세릴계 또는 지방산계중 하나 이상으로서, 배합량은 액정베이스계 전체중량에서 0.5-70중량%이다.Next, the co-emulsifier has a great nutrition for the liquid crystal formation and stability of the formed liquid crystal, the co-emulsifier used in the present invention is an ethoxylate-based, polyglyceryl-based or HLB (Hydrophilicity / Lipophilicity Balance) value of 10-15 As at least one of the fatty acid systems, the blending amount is 0.5-70% by weight based on the total weight of the liquid crystal base system.
이와 같은 보종유화제중 에톡실레이트계는 에톡실레이티드 콜레스테릴 지방알코올, 아세틸레이트 디 폴리소르베이트 80-세틸-라놀린 알코올 등으로서, 본 발명 액정베이스에는 이들중 1종 이상이 0.1-10중량% 배합되며, 폴리글리세릴계는 폴리글리세릴-3-카프레이트 및 폴리글리세릴-3-디이소스테아레이트 중 1종 이상으로서, 배합량은 0.1-15중량%이고, 지방산계는 글리세릴 모노스테아레이트로서, 배합량은 0.3-70중량%이다.The ethoxylates of these co-emulsifiers are ethoxylated cholesteryl fatty alcohols, acetylate dipolysorbate 80-cetyl-lanolin alcohols, and the like in the liquid crystal base of the present invention. % Is blended, the polyglyceryl is at least one of polyglyceryl-3-caprate and polyglyceryl-3-diisostearate, the compounding amount is 0.1-15% by weight, the fatty acid is glyceryl monostearate As a compounding quantity, it is 0.3-70 weight%.
다음에, 안정화제로서 콜레스테릴계가 사용되는데, 이와 같은 콜레스테릴계는 액정 형성의 주 기재로 작용하게 되며, 콜레스테롤, 피토스테롤, 콜레스테릴카보네이트 등으로서, 배합량은 액정베이스 전체에서 0.1-5.0중량%이다.Next, a cholesteryl system is used as a stabilizer, and such a cholesteryl system serves as a main substrate for liquid crystal formation, and as the cholesterol, phytosterol, cholesteryl carbonate, etc., the compounding amount is 0.1-5.0 weights in the whole liquid crystal base. %to be.
마지막으로, 변성불소계가 사용되는데, 이는 파우더에 의한 재응집 현상과 솔트인 및 솔트아웃(salt in & out) 작용을 방지하고 액정 형성의 안정성 향상을 도모하기 위한 것으로서, 트리프루오르 C14 알킬메치콘, 플루오르 C2-8 알킬디메치콘 등을 단독 또는 혼용하여 사용하며, 배합량은 액정베이스 전체에서 0.5-20.0중량%이다.Finally, the modified there is fluorine is used, which serves to prevent re-agglomeration and Salt in and salt out (salt in & out) operation by the powder and improved stability of the liquid crystal form, the tree fruit climb C 14 alkyl, methoxy Chicon, fluorine C 2-8 alkyldimethicone, etc. are used alone or in combination, and the compounding amount is 0.5-20.0 wt% in the entire liquid crystal base.
한편, 본 발명의 최종 메이크업 조성물에는 파운데이션 시스템에서의 액정 안정성을 위하여 디메치콘계와 트리페닐메치콘, 실리콘폴리머 등의 비휘발성계 실 리콘 물질이 주기재로 사용되는데, 이의 배합량은 메이크업 조성물 전체를 100으로 할 때 5-20중량%이다.Meanwhile, in the final makeup composition of the present invention, non-volatile silicone materials such as dimethicone, triphenylmethicone, and silicone polymer are used as main materials for liquid crystal stability in a foundation system. It is 5-20 weight% at 100.
또한, 폴리데신, 이소도데칸올, 스쿠알란, 유동파라핀 등의 하이드로 카본계 오일이 사용되며, 메이크업 조성물에서의 배합량은 조성물 전체를 100으로 할 때 2-10%이다.Hydrocarbon-based oils such as polydesine, isododecanol, squalane and liquid paraffin are used, and the compounding amount in the makeup composition is 2-10% when the total composition is 100.
이밖에, 밀착속도를 조절하기 위해 사이크로메치콘을 적당량 사용할 수도 있다.In addition, an appropriate amount of cyclomethicone may be used to control the adhesion speed.
이하 상기와 같은 성분들을 함유하는 본 발명 액정 베이스의 제조방법 및 이를 함유하는 메이크업 조성물의 제조공정을 보다 상세히 설명하면 다음과 같다.Hereinafter, the manufacturing method of the liquid crystal base of the present invention containing the above components and the manufacturing process of the makeup composition containing the same will be described in detail.
먼저, 보조유화제 및 변성불소를 80-85도씨로 가온하여 녹이고, 레시틴계를 투입하여 용해한 다음, 콜레스텔릴계를 가하여 녹인 후 실온으로 냉각하면 액정베이스가 제조된다.First, the co-emulsifier and denatured fluorine are heated and dissolved at 80-85 degrees Celsius, dissolved by adding a lecithin system, and then dissolved by adding a cholesteryl system and cooled to room temperature to prepare a liquid crystal base.
상기 액정베이스를 24시간 이상 방치한 후, 수중유형의 메이크업 조성물에 첨가하여 최종 메이크업 화장료를 제조하게 되는데, 이때 전체 메이크업 화장료에서의 액정베이스의 배합량은 0.5-5.0중량%, 바람직하게는, 1.0-3.0중량%이다.After the liquid crystal base is left for 24 hours or more, it is added to the oil-in-water makeup composition to prepare a final makeup cosmetic, wherein the blending amount of the liquid crystal base in the total makeup cosmetic is 0.5-5.0% by weight, preferably 1.0- 3.0 wt%.
이상과 같이 설명한 본 발명의 화장료 조성물은 그 제형에 있어서 특별히 한정되는 바가 없는데, 예를 들면, 메이크업 베이스, 파운데이션, 에멀젼팩트, 스킨커버, 립스틱 등의 제형을 가질 수 있다.The cosmetic composition of the present invention described above is not particularly limited in the formulation, for example, may have a formulation such as makeup base, foundation, emulsion pact, skin cover, lipstick.
또한, 각 제형의 화장료 조성물에 있어서, 상기한 성분들 이외의 성분들을 화장료의 제형 또는 사용 목적 등에 따라 당업자가 어려움 없이 적의 선정하여 배 합할 수 있다.In addition, in the cosmetic composition of each formulation, components other than the above components may be appropriately selected and combined without difficulty by those skilled in the art according to the formulation or purpose of use of the cosmetic.
이하, 본 발명을 실시예 및 이를 이용한 시험예로서 보다 구체적으로 설명하고자 하나 본 발명을 이에 제한하고자 하는 것은 아니다.Hereinafter, the present invention will be described in more detail as examples and test examples using the same, but the present invention is not intended to be limited thereto.
먼저, 하기 표 1의 조성에 따라 본 발명의 액정베이스를 제조하였다.First, the liquid crystal base of the present invention was prepared according to the composition of Table 1 below.
제조방법Manufacturing method
1) 1,2,3의 원료를 80-85도씨로 가온하여 용해시킨다.1) The raw materials of 1,2,3 are heated to 80-85 ° C and dissolved.
2) 상기 1)에 4, 5, 6의 원료를 순서대로 투입하고 교반, 용해 후 실온으로 냉각시킨다.2) The raw materials of 4, 5, and 6 are sequentially added to 1) above, followed by stirring and dissolution, followed by cooling to room temperature.
상기 실시예의 샘플에 대하여 액정 형성 유/무를 확인하기 위하여 편광 현미경(NIKON OPTIPHOT2-POL)으로 확인한 결과 청자색의 라멜라형 액정이 형성되었음을 알 수 있었다.In order to confirm the presence / absence of liquid crystal formation with respect to the sample of the above example, it was confirmed that a blue-violet lamellar liquid crystal was formed by a polarization microscope (NIKON OPTIPHOT2-POL).
다음에, 시험예를 위하여, 상기 표 1의 조성에 따라 제조된 액정베이스 샘플을 이용하여 하기 표 2의 조성으로 파운데이션 제형의 메이크업 조성물을 제조하여 실시예와 비교예로 하였다.Next, for the test example, using the liquid crystal base sample prepared according to the composition of Table 1 to prepare a makeup composition of the foundation formulation in the composition of Table 2 as an Example and Comparative Example.
제조방법Manufacturing method
1) 원료 1-4, 9-12를 70-75도씨로 가온하고, 원료 5-8을 분쇄기로 분쇄한 후 함께 호모믹서에 투입하여 분산시킨다.1) Warm the raw materials 1-4 and 9-12 to 70-75 degrees Celsius, grind the raw materials 5-8 with a grinder, and put them together in a homomixer to disperse.
2) 원료 13-21를 70-75도씨로 가온, 용해 한 후 상기 1)에 투입하여 10-15분간 유화시킨다. 2) After heating and dissolving the raw material 13-21 at 70-75 ° C, add it to 1) and emulsify for 10-15 minutes.
3) 원료 22-23를 상기 2)에 투입하여 1-2분간 유화시킨 후 30도씨까지 냉각시킨 다음 여과 저장한다. 3) The raw material 22-23 was added to 2) above, emulsified for 1-2 minutes, cooled to 30 ° C, and then filtered.
[시험예 1] 사용성 시험Test Example 1 Usability Test
상기와 같이 제조된 실시예와 비교예의 메이크업 화장료로서의 사용성을 시험하기 위하여, 각 실시예 또는 비교예 당 20-40세의 여성 50명을 대상으로 1개월 동안 매일 1회 사용하게 한 후 그 결과를 비교 평가하여 하기 표 3에 나타내었다.In order to test the usability as the makeup cosmetics of the Examples and Comparative Examples prepared as described above, 50 women 20-40 years old each Example or Comparative Example was used once daily for one month and then the results Comparative evaluation is shown in Table 3 below.
평가 기준: 아주 양호-5점, 양호-4점, 보통-3점, 다소 불만족-2점, 불만족-1점
Evaluation criteria: Very good -5, Good -4, Moderate -3, Slightly dissatisfied -2, Dissatisfied -1
상기 표에서 보는 바와 같이, 본 발명 실시예 조성물이 퍼짐성, 밀착력, 가벼움성 피부색의 선명성 등의 모든 평가 사항에서 비교예보다 훨씬 우수함을 알 수 있다. 또한, 액정베이스를 유상에 투입한 비교예 1에 비하여 수상에 투입한 실시예가 그 사용성이 훨씬 더 향상되었음을 알 수 있다.
As shown in the table, it can be seen that the inventive composition of the present invention is far superior to the comparative example in all evaluation matters such as spreadability, adhesion, light skin color clarity, and the like. In addition, it can be seen that the usability of the Example added to the water phase is much improved compared to Comparative Example 1 in which the liquid crystal base is added to the oil phase.
[시험예 2] 색채 비교시험Test Example 2 Color Comparison Test
상기 표 2에 따라 제조된 본 발명 실시예 1과 비교예 2를 이용하여 피부색채의 선명성을 C.C.M(Comprterized Color Matching System)으로 3회씩 측정하고 그 평균치를 하기 표 4에 나타내었다. 여기서 L값은 밝기(lightness)의 정도를 나타내며, 수치가 높을수록 밝기가 높음을 의미하고, 채도(Chroma)의 정도를 나타내는 C값은 높을수록 색채가 선명함을 의미한다.Using the Example 1 and Comparative Example 2 of the present invention prepared according to Table 2, the clarity of skin color was measured three times with a C.C.M (Comprterized Color Matching System) and the average values are shown in Table 4 below. Here, the L value represents the degree of lightness, and the higher the value, the higher the brightness, and the higher the C value representing the chroma, the sharper the color.
상기 표 4에 나타난 바와 같이 본 발명의 실시예가 명도가 높으며, 특히 채도가 높아 본 발명 파운데이션이 도포후 피부색을 밝게 하여주는 효과가 있음을 보여준다.
As shown in Table 4, the embodiment of the present invention is high in brightness, and particularly high in saturation, shows that the present invention has an effect of brightening the skin color after application.
[시험예 2] 보습효과 시험Test Example 2 Moisturizing Effect Test
본 발명 실시예와 비교예에 대한 보습효과를 시험하였다.Moisturizing effect was tested for the inventive examples and comparative examples.
25-35세의 여성 15명을 대상으로 실시예 1, 2와 비교예 1, 2를 각각 얼굴에 하루에 1회 6주간 도포한 후, TEWAMETER TM210(C+K electronic GmbH. Germany)를 이용하여 경피수분 손실량 즉, TEWL(Transepidermal Water Loss) 값을 시간 변화에 따른 TEWL 값 변화량 △TEWL로 측정하고, CORNEOMETER CM 820 PC(C+K electronic GmbH. Germany)를 이용하여 표피 수분량에 따른 전기전도도의 변화로 0에서 150까지 피부의 수분량을 수치화하여 보습효과를 측정하였다. 시험결과는 하기 표 5에 나타내었다.Example 1, 2 and Comparative Examples 1, 2 were applied to the face once a day for 6 weeks for 15 women aged 25-35 years, using TEWAMETER TM210 (C + K electronic GmbH. Germany). Transdermal moisture loss, that is, TEWL (Transepidermal Water Loss) value is measured as TEWL value change ΔTEWL over time, and changes in electrical conductivity according to epidermal moisture content using CORNEOMETER CM 820 PC (C + K electronic GmbH. Germany). Moisturizing effect was measured by quantifying the moisture content of the skin from 0 to 150. The test results are shown in Table 5 below.
또한, 보습효과의 지속성을 시험하기 위하여, 상기 방법에 따른 각각의 제품을 사용한 후 2hr, 4hr, 6hr에서 △TEWL 및 Corneometer Value를 측정하였으며, 그 결과를 하기 표 6에 나타내었다.In addition, in order to test the persistence of the moisturizing effect, after using each product according to the method was measured at ΔTEWL and Corneometer Value at 2hr, 4hr, 6hr, the results are shown in Table 6 below.
시험 결과, 실시예의 △TEWL 값이 비교예에 비해 커서 경피수분 손실이 6주후 효과적으로 개선되었음을 알 수 있었으며, 아울러, 피부의 수분량을 측정한 Corneometer Value에서도 실시예가 비교예에 비해 높은 증가를 보였다.As a result of the test, it was found that the ΔTEWL value of the Example was larger than that of the Comparative Example, so that the percutaneous moisture loss was effectively improved after 6 weeks, and the Example also showed a higher increase in the Corneometer Value, which measured the moisture content of the skin.
또한, 상기 표 6에 나타난 바와 같이 실시예의 △TEWL값, Corneometer Value가 증가함으로써 피부가 매우 촉촉해짐을 알 수 있었다. 이는 액정베이스가 수분 및 영양성분을 침투시키는 데에 효과적임을 입증하는 것으로 해석된다.
In addition, as shown in Table 6, it can be seen that the skin is very moist by increasing the ΔTEWL value and the Corneometer Value of the examples. This is interpreted to prove that the liquid crystal base is effective in penetrating moisture and nutrients.
상기한 바와 같이 본 발명에 따라 레시틴 조성물을 함유하는 액정베이스가 제공되고 이 액정베이스를 함유하는 메이크업 조성물이 제공됨으로써, 수분공급능력, 피부친화력, 우수한 안정성, 가벼운 사용성 등 수중유형 메이크업 조성물의 장점과 내수성, 지속성 등 유중수형 메이크업 조성물의 장점을 모두 가지며, 이에 따라 분산성이 우수하여 색의 선명성이 향상되고 피부색을 밝게 해주는 효과를 가지면서도 제조가 용이한 메이크업 화장료 조성물 및 그의 제조방법이 제공될 수 있게 되었다.
As described above, the liquid crystal base containing the lecithin composition is provided according to the present invention, and the makeup composition containing the liquid crystal base is provided, thereby providing the advantages of the oil-in-water makeup composition such as water supply ability, skin affinity, excellent stability, and light usability. It has all the advantages of a water-in-oil type makeup composition, such as water resistance and durability, and thus can be provided a makeup cosmetic composition and a method for preparing the same, which are excellent in dispersibility and have an effect of improving color clarity and brightening skin color. It became.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010033712A KR100713564B1 (en) | 2001-06-15 | 2001-06-15 | Oil-in-water makeup cosmetic composition containing a liquid crystal base and a manufacturing method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010033712A KR100713564B1 (en) | 2001-06-15 | 2001-06-15 | Oil-in-water makeup cosmetic composition containing a liquid crystal base and a manufacturing method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020095609A KR20020095609A (en) | 2002-12-28 |
KR100713564B1 true KR100713564B1 (en) | 2007-05-04 |
Family
ID=27709302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020010033712A Expired - Lifetime KR100713564B1 (en) | 2001-06-15 | 2001-06-15 | Oil-in-water makeup cosmetic composition containing a liquid crystal base and a manufacturing method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100713564B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180035645A (en) | 2016-09-29 | 2018-04-06 | 주식회사 엘지생활건강 | Lecithin emulsification composition containing lecithin and high-viscosity ester oil |
KR20200083737A (en) * | 2018-12-28 | 2020-07-09 | (주)파이온텍 | Multiple emulsion type liquid crystal emulsion containing aloe and method for preparing thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102663997B1 (en) * | 2018-10-31 | 2024-05-09 | (주)아모레퍼시픽 | Composite surfactant composition comprising lecithin |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6094903A (en) * | 1983-10-28 | 1985-05-28 | Nisshin Oil Mills Ltd:The | Cosmetic |
JPS61289013A (en) * | 1985-06-18 | 1986-12-19 | Pola Chem Ind Inc | Skin external agent |
JPH10251117A (en) * | 1997-03-11 | 1998-09-22 | Kose Corp | Cosmetic |
KR19990070886A (en) * | 1998-02-25 | 1999-09-15 | 윤동한 | Cosmetics comprising a liposome type particles having a plurality of internal particles and a method of manufacturing the same |
-
2001
- 2001-06-15 KR KR1020010033712A patent/KR100713564B1/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6094903A (en) * | 1983-10-28 | 1985-05-28 | Nisshin Oil Mills Ltd:The | Cosmetic |
JPS61289013A (en) * | 1985-06-18 | 1986-12-19 | Pola Chem Ind Inc | Skin external agent |
JPH10251117A (en) * | 1997-03-11 | 1998-09-22 | Kose Corp | Cosmetic |
KR19990070886A (en) * | 1998-02-25 | 1999-09-15 | 윤동한 | Cosmetics comprising a liposome type particles having a plurality of internal particles and a method of manufacturing the same |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180035645A (en) | 2016-09-29 | 2018-04-06 | 주식회사 엘지생활건강 | Lecithin emulsification composition containing lecithin and high-viscosity ester oil |
KR20200083737A (en) * | 2018-12-28 | 2020-07-09 | (주)파이온텍 | Multiple emulsion type liquid crystal emulsion containing aloe and method for preparing thereof |
KR102272304B1 (en) | 2018-12-28 | 2021-07-05 | (주)파이온텍 | Multiple emulsion type liquid crystal emulsion containing aloe and method for preparing thereof |
Also Published As
Publication number | Publication date |
---|---|
KR20020095609A (en) | 2002-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996023484A1 (en) | Cosmetic makeup composition | |
EP0330369A1 (en) | Skin conditioning composition | |
JPH02295912A (en) | Cosmetic | |
EP0534286A1 (en) | External skin care preparation | |
KR100697484B1 (en) | Liquid Crystal Compositions and Cosmetics | |
JPS63250311A (en) | water-in-oil cosmetics | |
KR20050018953A (en) | Vesicle dispersion and cosmetic containing the same | |
KR20160082054A (en) | Emulsifier-Free Cosmetic Composition of the Oil-in-Water Emulsion Type and Preparation Method Thereof | |
JPS62215510A (en) | Emulsified composition | |
KR100713564B1 (en) | Oil-in-water makeup cosmetic composition containing a liquid crystal base and a manufacturing method thereof | |
JP3557877B2 (en) | Cosmetics obtained by dispersing a lipid dispersion composition in an aqueous medium | |
KR100702340B1 (en) | Water-in-oil makeup cosmetic composition containing lecithin | |
KR101015384B1 (en) | Oil-in-water makeup cosmetic composition containing no emulsifier and method for preparing same | |
KR100983387B1 (en) | Oil-in-Water Type Cosmetics | |
WO2017133822A1 (en) | Water-in-oil emulsions which are based on cetyl diglyceryl tris(trimethylsiloxy)silyl ethyl dimethicone as emulsifier and are largely silicone oil-free | |
KR101094544B1 (en) | Foundation composition containing an encapsulated pigment and a method of manufacturing the same | |
KR100372773B1 (en) | Compositions of Make-up Cosmetics | |
KR102594145B1 (en) | Nanoemulsion of translucent formulation containing natural ceramide and manufacturing method thereof and manufacturing method of customized cosmetics including the same | |
CN115551465A (en) | Composition for caring and/or making up keratin materials | |
JPH11315015A (en) | Cosmetic and its production | |
KR102758716B1 (en) | Double layer cosmetic composition for make-up cleaning | |
JPH02258712A (en) | Water-in-oil type emulsified cosmetic | |
KR100702335B1 (en) | Make-up cosmetic composition containing a pigment surface-treated with a liquid crystal base and a manufacturing method thereof | |
KR100787797B1 (en) | Makeup cosmetic composition containing lecithin and its manufacturing method | |
KR0118875B1 (en) | Water-in-oil emulsified foundation composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20010615 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20060119 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20010615 Comment text: Patent Application |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20070125 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20070425 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20070425 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20100318 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20110411 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20110916 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20130410 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20130410 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140312 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20140312 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20160329 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170329 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20170329 Start annual number: 11 End annual number: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180329 Year of fee payment: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20180329 Start annual number: 12 End annual number: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190328 Year of fee payment: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20190328 Start annual number: 13 End annual number: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20200416 Start annual number: 14 End annual number: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20210405 Start annual number: 15 End annual number: 15 |
|
PC1801 | Expiration of term |
Termination date: 20211215 Termination category: Expiration of duration |